awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26784116-7A98747E-251A-408F-80B8-1D593B9112F5
Q26784116-7A98747E-251A-408F-80B8-1D593B9112F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26784116-7A98747E-251A-408F-80B8-1D593B9112F5
Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase
P2860
Q26784116-7A98747E-251A-408F-80B8-1D593B9112F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26784116-7A98747E-251A-408F-80B8-1D593B9112F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96c9af2443fab76773d4516000bf25d33987c320
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).